ESLA
ESLA
NASDAQ · Biotechnology

Estrella Immunopharma Inc

$1.45
+0.13 (+9.85%)
As of Feb 8, 2:17 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.42M 17.19M 14.45M
Net Income 959.9K 1.03M 875.1K
EPS
Profit Margin 5.2% 6.0% 6.1%
Rev Growth +1.0% +13.6% +14.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.50M 6.16M 6.85M
Total Equity 35.90M 38.17M 33.17M
D/E Ratio 0.15 0.16 0.21
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.74M 1.49M 1.43M
Free Cash Flow 993.5K 1.08M 606.8K